CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Biolingus Cayman Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Biolingus Cayman Ltd
Grossmatt 6
HERGISWIL, 6052  Switzerland
Business Summary
Biolingus Cayman Ltd is a Switzerland based holding Company, that operates in the biotechnology industry. The main and only segment that is undertaken by the Company is the development of oral, sublingual, delivery systems, in the more common sense, these are casings for various drugs that are to be taken orally. These systems, that are developed by the Company, are able to deliver peptides, and various proteins for chronic diseases, such as diabetes, obesity, and inflammatory diseases. The business operations are conducted through the Companies subsidiaries. The locations of the subsidiaries that the business operates through are in Switzerland, Hong Kong, the People’s Republic of China, and Australia.
(Source: 10KSB40)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
4/30/20234/30/2023-Yes---

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus
2834 Pharmaceutical preparations
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer YvesDecadt 56
Chief Financial Officer Chun PongHui 38 1/1/2023 1/1/2023
Director Sai YingKo 77
3 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 11,112,582 (As of 12/19/2023)


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, October 31, 2024